Inhibitory effect of dendritic cells pulsed with MAGE-3 peptide on transplanted murine gastric cancer in mice

National Medical Journal of China

Volumn 85, Issue 30, 2005, Pages 2120-2123

  Lü, Bin ^a   Liu, Bing Ya ^a   Zhang, Yi ^a   Chen, Xue Hua ^a   Zhu, Zheng Gang ^a   Yin, Hao Ran ^a   Lin, Yan Zhen ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Antigens, Neoplasms; Dendritic cells; MAGE; Stomach neoplasms

Indexed keywords

MELANOMA ANTIGEN 3; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CANCER TRANSPLANTATION; CELL CLONE; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; IMMUNIZATION; INFLUENZA VIRUS; INOCULATION; MONITORING; MOUSE; NONHUMAN; PROVOCATION TEST; STOMACH CANCER; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; MICE; MICE, INBRED STRAINS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; STOMACH NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 23844522013     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Brossart P. Dendritic cells in vaccination therapies of malignant diseases. Transfus Apheresis Sci, 2002, 27:183-186.
2. Cochlovius B, Stassar M, Christ O, et al. In vitro and in vivo induction of a Th cell response toward peptides of the melanoma-associated glycoprotein 100 protein selected by the TEPITOPE program. J Immunol, 2000, 165:4731-4741.
3. Steinman RM, Adams JC, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen. J Exp Med, 1975, 141:804-820.
4. Parmiani G, Castelli C, Dalerba P, et al. Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going? J Natl Cancer Inst, 2002, 94:805-818.
5. k for mouse gastric cancer. Shanghai J Immunol, 2003, 23:221-224.
6. Gould KG, Scotney H, Brownlee GG. Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin. J Virol, 1991, 65:5401-5409.
7. Toes RE, van der Voort EI, Schoenberger SP, et al. Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J Immunol, 1998, 160:4449-4456.
8. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature, 1998, 392:245-252.
9. Liu BY, Chen XH, Gu QL, et al. Antitumor effects of vaccine consisting of dendritic cells pulsed with tumor RNA from gastric cancer. World J Gastroenterol, 2004, 10:630-633.
10. Xu F, Wang S, Ye YJ. Dendritomas plays an important role in the activation of anti-tumor immune responses. Natl Med J China, 2004 84:725-729.
11. Hersey P, Menzies SW, Coventry B, et al. Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma. Cancer Immunol Immunother, 2005, 54:208-218.
12. Chen XH, Liu BY, Zhang DQ, et al. Expression of MAGE-1 and MAGE-3 genes in gastric cancer and gastric biopsy tissues and its clinical significance. Chin J Cell Mol Immunol, 2004, 20:310-313.